anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
MindMed · pitchdeck

MindMed | Investor Presentation Deck | 42 slides

42 pages · 5 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

MindMed | Investor Presentation Deck | 42 slides

MindMed · 2024-11
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 28 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 5 slides 100% 5/5 slides 100% 5/5 slides · 23 hits
— 0/5 slides
— 0/5 slides
40% 2/5 slides 100% 5/5 slides · 6 hits
— 0/5 slides
Solution 8 slides 100% 8/8 slides 100% 8/8 slides · 28 hits
— 0/8 slides
50% 4/8 slides 62.5% 5/8 slides 100% 8/8 slides 50% 4/8 slides Market Size 4 slides 100% 4/4 slides 100% 4/4 slides · 17 hits
— 0/4 slides
50% 2/4 slides 75% 3/4 slides 100% 4/4 slides 75% 3/4 slides Product 10 slides 100% 10/10 slides 100% 10/10 slides · 42 hits
— 0/10 slides
— 0/10 slides
30% 3/10 slides 100% 10/10 slides 20% 2/10 slides Team 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides · 2 hits
— 0/1 slides

Slide inventory

42
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Problem
02
other
Open slide detailBeat · Problem
03
The slide uses a hub-and-spoke layout to connect the central brand to five key operational pillars.inspire_vision
Open slide detailBeat · Problem
04
The slide uses a combination of headshots for the team and a logo grid for both past company experience and product experience.other
Open slide detailBeat · Problem
05
The chart uses horizontal bars to represent clinical trial phases for specific indications.plan_implementation
Open slide detailBeat · Problem
06
The slide uses a horizontal timeline structure to map clinical trial milestones.plan_implementation
Open slide detail
07
transition
Open slide detailBeat · Solution
08
Slide uses a list-based layout to present four distinct pillars of program progress.show_traction
Open slide detailBeat · Solution
09
The slide uses a matrix-like structure to contrast clinical efficacy, market opportunity, and unmet needs across two primary indications.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
10
The slide uses a process flow diagram to connect molecular interaction to clinical outcomes.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
11
The slide uses a structured layout to compare clinical trial designs across two primary indications.plan_implementation
Open slide detailBeat · SolutionLoop · Cost Of Inaction
12
The slide uses a structured list format to map specific clinical challenges to corresponding methodological solutions.plan_implementation
Open slide detailBeat · SolutionLoop · Cost Of Inaction
13
Uses a timeline-based framework to illustrate overlapping IP protections.present_framework
Open slide detailBeat · Solution
14
The slide features the company logo and a stylized brain-like graphic.front_matter
Open slide detailBeat · Solution
15
The slide uses a three-part vertical list structure to summarize clinical trial strategy.plan_implementation
Open slide detailBeat · Market Size
16
The slide uses a bar chart to visually demonstrate superiority over standard of care.compare_peers
Open slide detailBeat · Market SizeLoop · Pattern Hunter
17
The slide uses a list-based framework to map clinical outcomes to target product profile attributes.show_traction
Open slide detailBeat · Market SizeLoop · Pattern Hunter
18
The slide uses a timeline-like structure to show the progression from Part A to Part B for two distinct studies.plan_implementation
Open slide detailBeat · Market SizeLoop · Pattern Hunter
19
Includes study timeline, randomization, entry criteria, and endpoints.plan_implementation
Open slide detailBeat · ProductLoop · Pattern Hunter
20
The slide uses a process flow diagram to illustrate the study design.plan_implementation
Open slide detailBeat · ProductLoop · Pattern Hunter
21
The slide uses a callout box to link the primary endpoint to historical Phase 2b performance data.analyze_data
Open slide detailBeat · Product
22
front_matter
Open slide detailBeat · Product
23
The slide uses a table to establish historical and modern clinical validity for LSD therapy.cite_precedent
Open slide detailBeat · Product
24
The chart highlights statistical significance at specific time points (Week 1, 2, 4, 8, 12) using asterisks.show_traction
Open slide detailBeat · Product
25
The slide outlines the study structure for MM120-310, with MM120-311 design pending.plan_implementation
Open slide detailBeat · Product
26
Includes study design, randomization, primary endpoint, entry criteria, and secondary endpoints.plan_implementation
Open slide detailBeat · Product
27
front_matter
Open slide detailBeat · Product
28
The slide emphasizes regulatory alignment and standard clinical trial methodology.present_framework
Open slide detailBeat · Product
29
Includes study design, dosing arms, primary/secondary endpoints, and entry criteria.plan_implementation
Open slide detail
30
The slide uses a table to contrast what is included in the patient journey versus what is explicitly excluded (no preparation, no assisted therapy, no integratipresent_framework
Open slide detail
31
The slide uses a process flow diagram to track patient retention from randomization through 12 weeks.analyze_data
Open slide detail
32
The table shows n=194 total participants across 5 cohorts. HAM-A and CGI-S are standard clinical scales for anxiety and severity of illness.analyze_data
Open slide detail
33
The chart highlights the 100ug dose group performance relative to placebo and other doses.show_traction
Open slide detail
34
Data shows a clear dose-response relationship peaking at 100ug.show_traction
Open slide detail
35
MCP-Mod is a statistical methodology for dose-response modeling.analyze_data
Open slide detail
36
The chart demonstrates efficacy of a drug candidate in a clinical trial setting.show_traction
Open slide detail
37
The slide uses a structured list format to present clinical safety findings.analyze_data
Open slide detail
38
The table shows high incidence of specific events like Illusion and Nausea on Dosing Day, but very low incidence After Dosing Day, supporting the 'favorable tolanalyze_data
Open slide detail
39
transition
Open slide detail
40
The slide uses a biological process diagram to explain the drug's effect on neurotransmitters and subsequent clinical outcomes.present_solution
Open slide detail
41
The slide uses a bar chart to demonstrate efficacy in an animal model and an icon grid to summarize clinical benefits.present_solution
Open slide detail
42
This appears to be a closing or transition slide, though it functions as a cover-style branding slide.front_matter
Open slide detail